Literature DB >> 35471714

Pathophysiology of deep vein thrombosis.

Simón Navarrete1, Carla Solar1, Roberto Tapia2, Jaime Pereira3, Eduardo Fuentes1, Iván Palomo4.   

Abstract

Deep venous thrombosis is a frequent, multifactorial disease and a leading cause of morbidity and mortality. Most of the time deep venous thrombosis is triggered by the interaction between acquired risk factors, such as hip fracture, pregnancy, and immobility, and hereditary risk factors such as thrombophilias. The mechanisms underlying deep venous thrombosis are not fully elucidated; however, in recent years, important advances have shed light on the role of venous flow, endothelium, platelets, leukocytes, and the interaction between inflammation and hemostasis. It has been described that the alteration of venous blood flow produces endothelial activation, favoring the adhesion of platelets and leukocytes, which, through tissue factor expression and neutrophil extracellular traps formation, contribute to the activation of coagulation, trapping more cells, such as red blood cells. Thus, the concerted interaction of these phenomena allows the formation and growth of the thrombus. In this work, the main mechanisms involved in the pathophysiology of deep vein thrombosis will be described.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Coagulation; DVT; Endothelium; Leukocyte; Platelet; Venous valves

Year:  2022        PMID: 35471714     DOI: 10.1007/s10238-022-00829-w

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  100 in total

1.  The origin of deep vein thrombosis: a venographic study.

Authors:  A N Nicolaides; V V Kakkar; E S Field; J T Renney
Journal:  Br J Radiol       Date:  1971-09       Impact factor: 3.039

Review 2.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

Review 3.  Thrombosis and platelets: an update.

Authors:  Milka Koupenova; Beate E Kehrel; Heather A Corkrey; Jane E Freedman
Journal:  Eur Heart J       Date:  2017-03-14       Impact factor: 29.983

4.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.

Authors:  M D Silverstein; J A Heit; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  1998-03-23

5.  Thrombotic risk during pregnancy: a population study.

Authors:  P Lindqvist; B Dahlbäck; K Marŝál
Journal:  Obstet Gynecol       Date:  1999-10       Impact factor: 7.661

Review 6.  Venous thrombosis.

Authors:  Alisa S Wolberg; Frits R Rosendaal; Jeffrey I Weitz; Iqbal H Jaffer; Giancarlo Agnelli; Trevor Baglin; Nigel Mackman
Journal:  Nat Rev Dis Primers       Date:  2015-05-07       Impact factor: 52.329

7.  Third national registry of acute coronary syndromes (RENASICA III).

Authors:  Carlos Jerjes-Sanchez; Carlos Martinez-Sanchez; Gabriela Borrayo-Sanchez; Jorge Carrillo-Calvillo; Ursulo Juarez-Herrera; Juan Quintanilla-Gutierrez
Journal:  Arch Cardiol Mex       Date:  2015-08-31

8.  Polymorphisms in the protein C gene as risk factor for venous thrombosis.

Authors:  Elisabeth R Pomp; Carine J M Doggen; Hans L Vos; Pieter H Reitsma; Frits R Rosendaal
Journal:  Thromb Haemost       Date:  2009-01       Impact factor: 5.249

9.  Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.

Authors:  Leslie Raffini; Yuan-Shung Huang; Char Witmer; Chris Feudtner
Journal:  Pediatrics       Date:  2009-09-07       Impact factor: 7.124

Review 10.  Risk factors for venous thromboembolism.

Authors:  Frederick A Anderson; Frederick A Spencer
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

View more
  1 in total

Review 1.  The Therapeutic Roles of Cinnamaldehyde against Cardiovascular Diseases.

Authors:  Li Lu; Yuan Xiong; Juan Zhou; Guangji Wang; Bobin Mi; Guohui Liu
Journal:  Oxid Med Cell Longev       Date:  2022-10-08       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.